Skip to main content

Why Safe BPC-157 exists

The word safe asks for evidence about people. That is the question that brought this site into focus.

The safety question

Safe BPC-157 is a personal research-commentary site. The name asks whether a reassuring reputation survives a close look at who was studied and for how long. It makes no claim that the peptide is safe.

I began with more suspicion than interest. The rat tendon-strength result and the nerve experiment combining structure, signaling and movement gave me something substantial to consider. The two-adult intravenous pilot brought the human safety question back to a very small headcount.

The judgments here

Function, repetition by unrelated laboratories and sufficiently long safety observations count most for me. That is a preference about evidence, rather than a treatment recommendation.

An improvement in a rat can be remarkable on its own terms. A person describing less pain can be entirely sincere. I dispute the extra assurance often attached to those observations.

An intervention that changes blood-vessel growth raises questions outside the injury being treated. The VEGFR2 experiments leave my enthusiasm for repair tied to a concern about unwanted growth. Follow-up that examines harm as deliberately as tissue repair would address a question the word protective tends to obscure.

Health decisions and corrections

These pages cannot assess a person's health or select a treatment. Nothing here is medical advice. The site offers commentary rather than consultations or products.

A paper can overturn a judgment of mine. A correction that identifies the sentence and a source is more useful than a general vote of confidence or disapproval. The contact page sets out the correspondence details currently available.